We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01283087
Recruitment Status : Completed
First Posted : January 25, 2011
Last Update Posted : November 27, 2017
Information provided by (Responsible Party):
Britt-Marie Berling, Vestre Viken Ringerike Sykehus

Brief Summary:
The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.

Condition or disease
Transient Neurologic Symptoms

Study Type : Observational
Actual Enrollment : 168 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Spinal Anesthesia Using Lidocaine and Sufentanil and TNS (=Transient Neurological Symptoms)
Study Start Date : January 2011
Primary Completion Date : May 2016
Study Completion Date : May 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anesthesia
U.S. FDA Resources

Primary Outcome Measures :
  1. Symptoms of transient neurological symptoms [ Time Frame: 5 days ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients who are submitted for surgery at a local hospital and where spinal anesthesia is indicated.

Inclusion Criteria:

  • adults over the age of seventeen years

Exclusion Criteria:

  • patient refuse spinal anesthesia
  • spinal anesthesia is contraindicated
  • pregnancy
  • patient is incapable of giving consent
  • diabetes
  • neurological disorders
  • chronic pain
  • chronic use of analgesics
  • spinal anesthesia within five days before the actual surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01283087

Ringerike Sykehus
Hønefoss, Norway, No 3501
Vestre Viken HF Ringerike Sykehus
Hønefoss, Norway, NO-3510
Sponsors and Collaborators
Vestre Viken Ringerike Sykehus
Study Chair: halfdan Aas, MD, PhD Vestre Viken HF
Study Chair: halfdan Aas, MD, PhD VestreViken HF

Responsible Party: Britt-Marie Berling, MD, PhD, Vestre Viken Ringerike Sykehus
ClinicalTrials.gov Identifier: NCT01283087     History of Changes
Other Study ID Numbers: 400229
First Posted: January 25, 2011    Key Record Dates
Last Update Posted: November 27, 2017
Last Verified: November 2017

Keywords provided by Britt-Marie Berling, Vestre Viken Ringerike Sykehus:
Spinal anesthesia

Additional relevant MeSH terms:
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Local
Sensory System Agents
Peripheral Nervous System Agents
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Sodium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Adjuvants, Anesthesia
Anesthetics, Intravenous
Anesthetics, General